Jing Zhang

9PUBLICATIONS
52CO-AUTHORS
Gene and molecular therapyPsychosocial aspects of childbirth and perinatal mental healthEpidemiological modellingNgā tikanga rangahau o te Māori (Māori research methods)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 10, 2026
The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heart.

|Sep 28, 2024
Hypoxic stabilization of RIPOR3 mRNA via METTL3-mediated m6A methylation drives breast cancer progression and metastasis.

Jingjing Xiong, Zirui Zhou, Yulong Jiang

|Sep 04, 2023
A mitochondrial EglN1-AMPKα axis drives breast cancer progression by enhancing metabolic adaptation to hypoxic stress.

Weiwei Jiang, Mengyao Zhang, Chuan Gao

|Aug 17, 2023
A cleaved METTL3 potentiates the METTL3-WTAP interaction and breast cancer progression.

Chaojun Yan, Jingjing Xiong, Zirui Zhou

|Jul 13, 2023
Estrogen receptor α-mediated signaling inhibits type I interferon response to promote breast carcinogenesis.

Li-Bo Cao, Zi-Lun Ruan, Yu-Lin Yang

|May 19, 2023
α-Ketoglutarate-dependent Enzymes in Breast Cancer and Therapeutic Implications.

Jingjing Xiong, Chaojun Yan, Qing Zhang

Pageof 2

Frequent Collaborators

5 joint publications

Qing Zhang

2 joint publications

Jeremy Simon

2 joint publications

Chaojun Yan

2 joint publications

Zilun Ruan